Login
Related Links
Breaking Gene Therapy News
Breaking gene therapy news items collected via Google News. Current news results for 'gene therapy' are sorted by date. Login and view all archived news items.
- Cell therapy weekly: Clinical Trial Application Approval for Muscular Dystrophy Gene Therapy - RegMedNet
Thu, 28 Mar 2024 13:58:0 GMT - REGENXBIO reports promising gene therapy for eye disease - Investing.com South Africa
Thu, 28 Mar 2024 12:26:3 GMT - REGENXBIO and Abbvie Advance Wet AMD Gene Therapy to Phase III - Genetic Engineering & Biotechnology News
Thu, 28 Mar 2024 12:05:1 GMT - Robots and AI: The Future of Cell and Gene Therapy Manufacturing - Genetic Engineering & Biotechnology News
Wed, 27 Mar 2024 17:00:2 GMT - Gene therapy offers hope for giant axonal neuropathy patients - UT Southwestern
Wed, 27 Mar 2024 16:52:2 GMT - Gene Therapy, DNA's Past, RNA's Future: Early History - Forbes
Wed, 27 Mar 2024 16:20:5 GMT - Nanoscope Claims Phase II Win for Gene Therapy After Changing Primary Endpoint - BioSpace
Wed, 27 Mar 2024 16:18:4 GMT - Atamyo's gene therapy for LGMD2C/R5 cleared to enter clinic in Europe - BioWorld Online
Wed, 27 Mar 2024 14:00:0 GMT - Intellia ending work with Regeneron on hemophilia B gene therapy - Hemophilia News Today
Wed, 27 Mar 2024 13:35:0 GMT - Atamyo obtains clearance for muscular dystrophy gene therapy trial in Europe - Clinical Trials Arena
Wed, 27 Mar 2024 12:26:4 GMT - Competitive Intelligence Insights: Cell & Gene Therapy - Evaluate Pharma
Wed, 27 Mar 2024 11:55:4 GMT - Gene therapy maker bluebird to revise financials after accounting errors - Reuters
Tue, 26 Mar 2024 15:55:0 GMT - Why Alzheimer's Drug Approval Delay? $3 Billion in DMD Gene Therapy; ADHD Prevalence - Medpage Today
Tue, 26 Mar 2024 15:17:1 GMT - Maryland non-profit sets up gene therapy production in Brazil - FiercePharma
Tue, 26 Mar 2024 13:44:2 GMT - Gene therapy maker bluebird to restate financials after accounting errors - Investing.com
Tue, 26 Mar 2024 13:33:4 GMT - Opus Genetics Announces Completion of Dosing in First Cohort of Phase 1/2 Trial of Gene Therapy OPGx-LCA5 in ... - Yahoo Finance
Tue, 26 Mar 2024 13:00:0 GMT - Nanoscope preps filing for retinitis pigmentosa gene therapy - pharmaphorum
Tue, 26 Mar 2024 12:11:3 GMT - First gene therapy for children with metachromatic leukodystrophy approved by FDA - Medical Xpress
Mon, 25 Mar 2024 14:35:0 GMT - FDA approves new gene therapy treatment for kids priced at $4.25 million - NewsNation Now
Sun, 24 Mar 2024 04:12:4 GMT - FDA Updates for Week of March 18, 2024: A $4.25 Million Gene Therapy and Drugs for Duchenne and Leukemia - Managed Healthcare Executive
Sat, 23 Mar 2024 14:05:3 GMT - Gene therapy for rare neuropathy displays potential in NIH trial - Clinical Trials Arena
Fri, 22 Mar 2024 17:47:5 GMT - Who Will Pay for Sickle Cell Gene Therapy? - Pain Medicine News
Fri, 22 Mar 2024 05:04:1 GMT - Gene Therapy for MLD Gets FDA Approval, Hefty Price Tag - Pharmacy Practice News
Thu, 21 Mar 2024 22:56:0 GMT - NICE not set to recommend reimbursement for SCD gene therapy Casgevy - Sickle Cell Disease News
Thu, 21 Mar 2024 19:00:2 GMT - The World's Most Expensive Drug Is Now a $4.25 Million Gene Therapy - TIME
Thu, 21 Mar 2024 14:46:4 GMT - Delivery and manufacturing hurdles remain in the cell and gene therapy - Pharmaceutical Technology
Thu, 21 Mar 2024 12:22:2 GMT - First-ever gene therapy approach for peripheral neuropathy in obese/diabetic mice - Wexner Medical Center - The Ohio State University
Thu, 21 Mar 2024 08:00:0 GMT - Cell Therapy Weekly: Krabbe Disease Gene Therapy Receives Innovation Passport - RegMedNet
Thu, 21 Mar 2024 08:00:0 GMT - Experimental gene therapy for giant axonal neuropathy shows promise in NIH clinical trial - National Institutes of Health (NIH) (.gov)
Wed, 20 Mar 2024 21:54:5 GMT - Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag - Reuters
Wed, 20 Mar 2024 17:00:0 GMT
Special News Items
- FDA approves Orchard’s Lenmeldy gene therapy for MLD
- Team performs the first gene therapy tests in a whole human liver
- Gene Therapy Success in Hereditary Angioedema Patients
- FDA Approves CRISPR Gene Therapy to Treat Blood Disorder
- FDA Signals Imminent Approval for Sarepta’s Duchenne Gene Therapy: A Major Breakthrough for Patients
- Revolutionary gene therapy shows promise in treating autism
- Cell & Gene Therapy Space Gears Up for First CRISPR Approval
- Gene therapy restores hearing in children with rare form of deafness
- UK biotech AlveoGene launches with plans for inhaled gene therapy
- Gene Therapy Targets Chronic Pain
- Gene therapy eyedrops restored a boy's sight. Similar treatments could help millions
- Gene therapy approved by FDA for certain boys with rare genetic condition
- FDA Needs More Cell, Gene Therapy Mid Managers to Speed Reviews
- Biology Professor Venigalla Rao Makes Breakthrough on Gene Therapy Research
- Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS)
- Bacterial ‘Nanosyringe’ Could Deliver Gene Therapy to Human Cells
- EU approves Hemgenix, one-time gene therapy for hemophilia B
- FDA officials offer advice on gene therapy trials
- New gene therapy delivers treatment directly to brain
- FDA approves Ferring’s Adstiladrin as first gene therapy for bladder cancer
- FDA Approves First Gene Therapy for Hemophilia B
- FDA finalizes neurodegenerative disease gene therapy guidance
- Gene Therapy Rapidly Improves Night Vision in Adults with Congenital Blindness
- Codex DNA's BioXp 9600 System debuting at CAR-TCR Summit
- BioMarin reports cancer case in hemophilia gene therapy trial
- Novartis Confirms Deaths of Two Patients Treated with Gene Therapy Zolgensma
- First patient in the Netherlands successfully treated with stem cell gene therapy
- One-time gene therapy injection could provide HIV treatment that may last a lifetime
- Gene therapy to cure leukemia at one-tenth global costs in the works
- Gene Therapy Successfully Treats Spinal Cord Injuries Without Side Effects